Mustang Bio, Inc's. (MBIO) interim Chief Financial Officer James Murphy has resigned on November 12, 2024.
Mustang Bio said Friday in the SEC filing that Murphy departure wasn't the result of a disagreement on any matter relating to the company's operations, policies or practices.
On November 15, 2024, the company's Board appointed Manuel Litchman, President and Chief Executive Officer, as Interim Chief Financial Officer, effective immediately.
Earlier this week the company said that Nasdaq Hearings Panel approved its request for an extension through January 31, 2025, to demonstrate compliance with $1 bid price requirement through January 31, 2025 and the $2.5 million stockholders' equity requirement, through February 18, 2025.
The company said it is considering all options available to it to regain compliance with the Rules within the extension periods granted by the Panel; however, there can be no assurance that the company will be able to do so.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.